• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS, EUROPE; LEFT VENTRICULAR ASSIST DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS, EUROPE; LEFT VENTRICULAR ASSIST DEVICE Back to Search Results
Catalog Number 104912
Device Problems Partial Blockage (1065); Detachment Of Device Component (1104); High Readings (2459); Device Dislodged or Dislocated (2923)
Patient Problems Heart Failure (2206); Obstruction/Occlusion (2422)
Event Date 08/21/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Approximate age of device ¿ 4 years, 5 months.The device was returned for analysis.The evaluation is not complete.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is complete.
 
Event Description
The patient was implanted with a left ventricular assist device (lvad) on (b)(6) 2012.It was reported that on (b)(6) 2016, the patient was admitted to the hospital due to elevated pump powers.An echocardiogram showed that there was no flow through the pump.Extracorporeal membrane oxygenation (ecmo) was initiated to stabilize the patient.A ct scan showed a completely thrombosed outflow graft and a decision to perform a pump exchange was made.It was reported that during the explant of the pump, the surgeon observed that the outflow graft bend relief was disengaged and had kinked the outflow graft, which appeared to be the reason that the pump and the outflow graft thrombosed in such a short time.The outflow graft was also reported to have a rupture in it that was located directly proximal to the area where the outflow graft bend relief connects to the outflow graft conduit.The complete lvad system was exchanged.No further information was provided.
 
Manufacturer Narrative
The evaluation of the returned device as well as the photos submitted by the hospital confirmed the report of a disengaged sealed outflow graft bend relief, a distorted/torn sealed outflow graft, and device thrombosis associated with a low flow condition.The sealed outflow graft conduit was returned with the bend relief detached from the graft attachment and the outflow graft was returned in two pieces.Examination of the proximal severed portion of the sealed outflow graft revealed a tear in the material adjacent to the graft attachment, which appeared consistent with abrasion against the metal bend relief attachment clip.Examination of the inlet tube, inflow graft, graft attachment, and returned portions of the outflow graft revealed depositions of loosely clotted blood and tissue-like clotted blood.The inlet elbow was occluded with loosely clotted blood and grainy denatured blood.Upon disassembly of the returned device, soft depositions of grainy denatured blood as well as hard, denatured blood were found throughout the body of the pump.The hard depositions around the body of the rotor, on the lumen of the blood tube, and surrounding the outlet bearing ball were strongly adhered to the blood-contacting surfaces.All of the observed depositions appeared to have developed as a result of poor surface washing due to a low flow situation or interruption in flow through the pump.The disengagement of the sealed outflow graft bend relief and subsequent distortion and perforation of the outflow graft would have caused inadequate flow through the pump, resulting in thrombus formation.The depositions found in the pump would have caused increased rotor drag, resulting in the reported elevation in pump power.Visual inspection of the pump bearings, rotor, and blood-contacting surfaces did not reveal any anomalies.Electrical continuity testing of the returned portion of the percutaneous lead did not reveal any discontinuities or shorts.Functional testing of the pump under normal operating conditions revealed normal pump power consumption and pressure values comparable to the data recorded during the manufacturing process and the pump operated as intended.Reports of disconnection of the bend relief from the sealed outflow graft have been addressed through the manufacturer's corrective/preventative action system, updated device labeling, an urgent medical device correction notice (2916596-2/24/12-001-c) and a sealed outflow graft bend relief collar (sobr collar) used to secure the bend relief to the sealed outflow graft and increase the assembly¿s resistance to forces that would tend to dislodge the bend relief.This design modification was approved in a pma supplement and has been implemented.The event occurred in (b)(6) where the pump was implanted 4 days after the correction notification and prior to the ce mark approval for the sobr collar.A review of the device history records revealed no deviations from manufacturing or quality assurance specifications.Device thrombosis is listed in the instructions for use as a potential adverse event that may be associated with the use of the heartmate ii left ventricular assist system.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS, EUROPE
Type of Device
LEFT VENTRICULAR ASSIST DEVICE
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564071
MDR Report Key5959173
MDR Text Key54992117
Report Number2916596-2016-01814
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Notification
Type of Report Initial,Followup
Report Date 08/23/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/30/2013
Device Catalogue Number104912
Other Device ID NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/09/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/23/2016
Initial Date FDA Received09/18/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/28/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/28/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Removal/Correction Number2916596-2/24/12-001-C
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age51 YR
Patient Weight75
-
-